About ZiliaZilia is a health technology company developing a breakthrough platform to measure biomarkers in the eye, with an initial focus on ocular oximetry.
Sight is an innate part of how we experience life, make meaning of our environment, and connect with the world around us.
Sadly, the only way to detect the leading causes of preventable blindness such as glaucoma, diabetic retinopathy, and age-related macular degeneration is by examining existing damage to the eye which often means it’s too late for meaningful intervention.
Founded on an ambitious vision, two brothers embarked on a bold mission to revolutionize the way we care for our sight. Dr. Patrick Sauvageau (trained optometrist and visual scientist) and Dominic Sauvageau (PhD in engineering) joined forces to bridge a critical gap in how eye disease is prevented, diagnosed, and managed.
Officially launched in 2017, Zilia is headquartered in Quebec City, Canada.
Six years after founding their health technology company, Zilia Ocular, the very first retinal camera to measure the oxygen saturation in the tissue of the eye is now being introduced to the world.
Leveraging the power of advanced imaging, spectroscopy, and artificial intelligence, Zilia developed a breakthrough platform that measures critical biomarkers in the eye and generates actionable data about the eye’s metabolic activity. This means we are now on the precipice of making early detection of the leading causes of preventable blindness accessible to all.
By using the eye as a window to health, we aim to expand our platform and develop the most comprehensive, accessible, and leading-edge healthcare solutions.
With our unique technologies, we not only strive to set a new standard for the way eye care is delivered, but also envision our technology adapting and evolving to impact an array of medical disciplines from neurology, cardiology, and oncology to intensive care, and rapid therapy monitoring for drug research and development.
Zilia is driven to make a transformational impact in real lives by redefining the way we prevent, diagnose, and treat various ocular, neurological, and systemic conditions. We’re invested in building a brighter future where everyone can protect and optimize their vision with ease.
Join us on a remarkable journey to reshape the future of eye care and beyond.